AV-078
- Generic Name
- AV-078
AI and Multi-Omics Drive Breakthrough Advances in Anti-Aging Drug Development
• Recent advances in AI, deep learning, and multi-omics technologies have enabled researchers to identify key pathways for anti-aging drug development, with promising results emerging from early clinical trials.
• Multiple FDA-approved drugs, including rapamycin and metformin, have demonstrated anti-aging potential, leading to increased investment in drug repurposing and development of improved variants.
• Major biotech companies like Rubedo Life Sciences, Aeovian Pharmaceuticals, and Insilico Medicine are advancing novel anti-aging drug candidates, with total industry investment reaching $6.2 billion in 2021.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath